Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (NASDAQ: IDXX) and Icon plc (NASDAQ: ICLR)

By Carrie Williams

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Idexx Laboratories (NASDAQ: IDXX) and Icon plc (NASDAQ: ICLR).

Idexx Laboratories (NASDAQ: IDXX)

Idexx Laboratories (NASDAQ: IDXX) received a Buy rating from C.L. King analyst David Westenberg on July 28. The company’s shares closed on Friday at $167.52, close to its 52-week high of $173.01.

According to TipRanks.com, Westenberg is a 3-star analyst with an average return of 24.2% and a 66.7% success rate. Westenberg covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, Heska Corp, and Illumina.

Idexx Laboratories has an analyst consensus of Strong Buy, with a price target consensus of $182.50.

Icon plc (NASDAQ: ICLR)

Mizuho Securities analyst Ann Hynes assigned a Hold rating to Icon plc (NASDAQ: ICLR) on July 27 and set a price target of $108. The company’s shares closed on Friday at $102.84, close to its 52-week high of $107.72.

According to TipRanks.com, Hynes is a 4-star analyst with an average return of 7.0% and a 61.4% success rate. Hynes covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quintiles Transnational, and Quest Diagnostics Inc.

Currently, the analyst consensus on Icon plc is Moderate Buy and the average price target is $109.50, representing a 6.5% upside.

In a report issued on July 17, Barclays also maintained a Hold rating on the stock with a $103 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.